Encounter for Screening for Malignant Neoplasm of Colon: How It Works, Results and What to Expect

An encounter for screening for malignant neoplasm of colon is a preventive healthcare visit or test performed to look for colon cancer and precancerous polyps in people without concerning symptoms. Screening can identify polyps before they become cancerous and can detect cancer at an earlier, more treatable stage.

Overview: What Does an Encounter for Screening for Malignant Neoplasm of Colon Mean?

An encounter for screening for malignant neoplasm of colon refers to a preventive medical appointment, discussion, or test intended to look for colon cancer or precancerous growths before a person develops symptoms. It may be documented during a routine check-up, referral to a gastroenterologist, stool-based test, or colonoscopy appointment.

Screening differs from diagnostic testing. Screening is performed in people who feel generally well and do not have warning signs of colorectal disease. Diagnostic testing is used when a person has symptoms such as rectal bleeding, unexplained iron-deficiency anemia, a persistent bowel-habit change, or unexplained weight loss.

Colon and rectal cancers are often grouped as colorectal cancer because they arise in neighboring parts of the large intestine and share many screening approaches. Many colon cancers begin as polyps, which are growths in the bowel lining. Finding and removing certain polyps can help prevent cancer from developing.

Why Would a Doctor Order a Screening for Malignant Neoplasm of Colon?

A doctor may order colon cancer screening because it is an important form of preventive care. The purpose is to identify cancer at an early stage, when it may cause no symptoms, and to find polyps that can often be removed before they become cancerous.

For adults at average risk, many guidelines recommend beginning regular colorectal cancer screening at age 45 and continuing through age 75. Decisions after that age are individualized, considering overall health, previous screening findings, life expectancy, and personal preferences. Recommendations can differ between countries and healthcare systems, so the clinician will advise an appropriate plan.

Screening may need to start earlier or be performed more often for people with a parent, sibling, or child affected by colorectal cancer or advanced polyps; a personal history of polyps or colorectal cancer; inflammatory bowel disease; prior abdominal or pelvic radiation; or an inherited cancer syndrome. A clinician may refer patients with concerning personal or family histories for specialist assessment.

• Average-risk adults may choose from several validated screening tests.
• People at higher risk may be advised to have colonoscopy rather than a stool-based test.
• Any abnormal screening result should be followed according to the test result and the individual’s risk profile.

How Colon Cancer Screening Works and Who May Be a Candidate

Colon cancer screening tests generally work in one of two ways: they look for blood or abnormal DNA in stool, or they examine the inside of the colon for polyps and cancer. The most suitable option depends on a person’s medical history, risk level, access to testing, and willingness to complete follow-up testing if needed.

Stool-based tests can be completed at home and returned to a laboratory. A fecal immunochemical test (FIT) checks for small amounts of blood that may not be visible. Stool DNA tests assess blood and selected DNA changes associated with some colorectal cancers and polyps. These tests are repeated at intervals because a single negative test does not permanently rule out future disease.

Visual tests include colonoscopy, CT colonography and, in some settings, flexible sigmoidoscopy. Colonoscopy allows a specialist to inspect the full colon and remove many polyps immediately. It is often recommended after an abnormal stool test and may be preferred for people at increased risk. The choice should be made with a qualified clinician after discussing benefits, preparation, potential limitations, and follow-up requirements.

What Happens During a Screening Colonoscopy?

Before colonoscopy, the bowel must be cleared so the clinician can view the lining accurately. Patients receive specific instructions about temporary dietary changes, a prescribed bowel-cleansing preparation, and which regular medicines may need adjustment. It is particularly important to discuss blood thinners, diabetes medicines, kidney disease, pregnancy, and any prior problems with sedation or bowel preparation.

On the day of the procedure, a healthcare team reviews medical history, allergies, medicines, and consent. Sedation or anesthesia is commonly used to keep the person comfortable. A flexible, camera-equipped tube is carefully passed through the rectum and along the colon while the clinician examines the bowel lining.

If polyps are found, they can often be removed during the same procedure and sent to a laboratory for examination. Tissue samples may also be taken when needed. A screening colonoscopy commonly takes less than an hour, although preparation, check-in, recovery, and discharge planning make the appointment longer. Because sedation may affect alertness, patients generally need someone to accompany them home.

For people who require further assessment of polyps, suspected cancer, or an abnormal screening test, colon cancer treatment evaluation may involve gastroenterology, pathology, radiology, surgery, and oncology specialists.

Results, Recovery Timeline, Benefits and Risks

Some colonoscopy findings can be discussed soon after the procedure, but biopsy and polyp pathology results usually take longer. A normal result means no concerning growths were seen at that time; the clinician will recommend when screening should next be repeated. If a polyp is removed, the next colonoscopy interval depends on its number, size, appearance, and laboratory findings.

A positive stool test does not mean that a person has cancer. Blood in stool can occur for several reasons, and stool DNA tests can also be abnormal without cancer being present. However, an abnormal stool-based screening test requires timely follow-up, usually with colonoscopy, to determine the cause.

After colonoscopy, mild bloating, gas, or temporary cramping can occur as air is removed from the bowel. Most people return to usual eating and activities the next day, but they should follow discharge instructions and avoid driving, alcohol, or important decisions until sedation has fully worn off. Recovery after stool testing is immediate because there is no procedure or sedation.

The main benefits of screening are preventing some cancers through polyp removal and finding cancer earlier. Risks from colonoscopy are uncommon but include bleeding after polyp removal, a tear in the colon wall, reaction to sedation, missed lesions, and incomplete examination. The clinical team weighs these risks against expected benefits and helps select an appropriate test.

Can Malignant Neoplasms of the Colon Be Cured?

Some malignant neoplasms of the colon can be cured, particularly when they are found before they have spread widely. Treatment and outlook depend on the cancer’s stage, location, biology, a person’s overall health, and whether it can be completely removed or controlled with treatment.

Surgery is commonly the main treatment for localized colon cancer and involves removing the affected segment of colon with nearby lymph nodes. Depending on the stage and pathology results, chemotherapy may be recommended before or after surgery. Advanced disease may be treated with combinations of systemic therapy, surgery in selected situations, targeted therapy, immunotherapy, radiation in particular clinical circumstances, and supportive care.

Screening does not diagnose every cancer and cannot guarantee prevention, but it increases the opportunity to detect disease earlier. When cancer is diagnosed, care is best planned by an experienced multidisciplinary team. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support diagnosis and treatment planning for international patients.

Is Colon Cancer Screening Worth It?

For most eligible adults, colon cancer screening is worthwhile because it can prevent some colorectal cancers and can find others before symptoms appear. Different screening methods offer different advantages, and the best test is often the one a person can complete correctly and repeat at the recommended interval.

Stool tests are noninvasive and convenient, but a positive result must be followed by colonoscopy. Colonoscopy requires bowel preparation and sedation in many cases, yet it directly examines the colon and allows immediate removal of many polyps. CT colonography is less invasive but still requires bowel preparation, may identify findings outside the colon, and requires colonoscopy if a significant polyp is found.

A conversation with a clinician can help patients choose a method that fits their risk, medical needs, preferences, and local availability. Screening is not a substitute for medical assessment when symptoms occur; new or persistent symptoms should be investigated even if a recent screening test was normal.

What Is the Biggest Red Flag for Colon Cancer and When to Seek Medical Care?

Rectal bleeding or blood in the stool is an important red flag for colon cancer, but it is not the only one and does not always indicate cancer. Hemorrhoids, fissures, infections, inflammatory conditions, and other causes can also lead to bleeding. Still, bleeding should not be assumed to be harmless without medical advice, particularly when it is new, recurrent, or accompanied by other changes.

Medical assessment is advisable for persistent changes in bowel habits, such as new constipation or diarrhea; stools that become consistently narrower; ongoing abdominal discomfort; unexplained iron-deficiency anemia; unusual fatigue; unintentional weight loss; or a sense that the bowel does not empty fully. These symptoms do not diagnose colon cancer, but they warrant evaluation.

Urgent medical care is appropriate for heavy rectal bleeding, black or tarry stools, fainting, severe or worsening abdominal pain, repeated vomiting, or symptoms of bowel obstruction such as marked bloating and inability to pass stool or gas. People with symptoms are generally assessed diagnostically rather than scheduled for routine screening alone.

Frequently asked questions

What does encounter for screening for malignant neoplasm of colon mean?

It is a medical coding and clinical term for a preventive visit or test to look for colon cancer in a person without symptoms. The encounter may include discussing risk, selecting a test, completing a stool test, or undergoing a colonoscopy.

At what age should colon cancer screening begin?

Many major guidelines recommend starting screening at age 45 for adults at average risk. People with a strong family history, inherited cancer syndrome, inflammatory bowel disease, or prior polyps may need earlier or more frequent screening.

How long does it take to get colonoscopy results?

The clinician may share visual findings shortly after the procedure once the effects of sedation are improving. If polyps or biopsies are sent to a laboratory, final pathology results commonly take several days to about two weeks, depending on the laboratory and healthcare setting.

What happens if a stool test for colon cancer is positive?

A positive stool test means additional evaluation is needed, usually a colonoscopy. It does not confirm cancer, as blood or abnormal DNA markers may have causes other than cancer, but follow-up should not be delayed.

Can a colonoscopy prevent colon cancer?

Colonoscopy can help prevent some colon cancers because many potentially precancerous polyps can be removed during the examination. It cannot prevent every cancer, and regular follow-up should be based on the clinician’s recommendations and pathology findings.

Do people with colon cancer always have symptoms?

No. Early colon cancer and polyps may not cause noticeable symptoms, which is why screening is valuable for eligible adults. Symptoms can develop later and should be medically assessed even after a previous normal screening test.

References

• World Health Organization
• U.S. Preventive Services Task Force
• American Cancer Society
• National Cancer Institute
• European Society for Medical Oncology

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.